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Glucose transport in skeletal muscle is mediated by two distinct transporter isoforms, designated muscle/adipose glucose
transporter (Glut4) and erythrocyte/HepG2/brain glucose transporter (Glutl), which differ in both abundance and
membrane distribution. The present study was designed to investigate whether differences in insulin responsiveness of red
and white muscle might be due to differential expression of the glucose transporter isoforms. Glucose transport, as well
as Glutl and Glut4 protein and mRNA levels, were determined in red and white portions of the quadriceps and
gastrocnemius muscles of male Sprague-Dawley rats (body wt. approx. 250 g). Maximal glucose transport (in response
to 100 nM-insulin) in the perfused hindlimb was 3.6 times greater in red than in white muscle. Red muscle contained
approx. 5 times more total Glut4 protein and 2 times more Glut4 mRNA than white muscle, but there were no differences
in the Glutl protein or mRNA levels between the fibre types. Our data indicate that differences in responsiveness of
glucose transport in specific skeletal muscle fibre types may be dependent upon the amount of Glut4 protein. Because this
protein plays such an integral part in glucose transport in skeletal muscle, any impairment in its expression may play a
role in insulin resistance.
INTRODUCTION
Skeletal muscle comprises a large percentage of the body mass
and is the primary tissue responsible for the disposal of an oral
glucose load (Defronzo et al., 1985). Skeletal muscle is composed
of a mixture of different fibre types (Nemeth & Pette, 1981)
which are generally classified by their contractile and metabolic
characteristics, as well as by colour. Red muscle fibres can be
either slow- or fast-contracting and have a high oxidative
capacity, whereas white fibres are fast-contracting and glycolytic.
Insulin sensitivity and the maximal rate of glucose transport are
also different between red and white muscle fibres (James et al.,
1985; Richter et al., 1988), with white muscle fibres being less
sensitive and less responsive to insulin than red muscle fibres.
Differences in glucose transport between skeletal muscle fibre
types have been proposed to be an important factor responsible
for various insulin-resistant states (Krotkiewski & Bj6rntrop,
1986; Lillioja et al., 1987). Elucidation of the mechanisms
responsible for the differences in glucose transport between
different skeletal muscle fibre types may help us to understand
the mechanisms responsible for insulin-resistant states.
It is now recognized that glucose transport in skeletal muscle
is mediated by two distinct isoforms, designated muscle/adipose
glucose transporter (Glut4) and erythrocyte/HepG2/brain glu-
cose transporter (Glutl). We have previously reported that
glucose transport in human muscle strips incubated in vitro is
impaired in obese individuals compared with lean controls, and
this most probably plays an important role in the whole-body
insulin resistance seen with obesity (Dohm et al., 1988). Likewise,
muscle from streptozotocin-diabetic rats has a reduced rate of
glucose transport (Wallberg-Henriksson, 1987) and contains
fewer glucose transporters than that from control animals
(Ramlal et al., 1989). Ramlal et al. (1989) concluded that this
decrease in the number of glucose transporters is at least partially
responsible for the decrease in glucose metabolism seen in the
diabetic condition.
Because decreased insulin responsiveness of glucose transport
observed in streptozotocin-induced diabetes is caused by
decreased levels of the glucose transporter protein, we
hypothesized that the mechanism responsible for the differences
in red and white muscle glucose transport may also be due to
different levels of the glucose transporter protein. We measured
glucose transport and the levels of glucose transporter protein
and mRNA in red and white skeletal muscle from rats.
MATERIALS AND METHODS
Animals
Male Sprague-Dawley rats weighing approx. 250 g were used
in all three phases of this experiment. Animals were housed
individually, maintained on a 12 h light/dark cycle (light from
03:00 to 15:00 h) and provided with food and water ad libitum.
Rats used for hindquarter perfusion were anaesthetized with
Innovar-Vet (0.04 mg/100 g) and prepared for perfusion.
Animals used for quantification of glucose transporter protein
and mRNA isolation were killed after an overnight fast. Gastro-
cnemius and quadriceps muscles were quickly removed and
separated by visual inspection into red and white portions, and
were either quick-frozen in clamps cooled in liquid N2 for glucose
transporter protein determination or immediately homogenized
for mRNA analysis.
3-O-Methylglucose transport into perfused hindquarter
The hemicorpus was prepared for perfusion using methods
previously described (Dohm et al., 1980). The perfusion medium
(4% BSA, 1.0 mM-pyuvate, 30% washed bovine red blood cells
and Krebs-Henseleit buffer) was gassed with 02/CO2 (19:1),
and contained the appropriate insulin concentration. The flow
rate was maintained at 18 ml/min. After discarding the first
50 ml of perfusate flowing through the animal, the remaining
100 ml volume was recirculated. At the end of a 30 min pre-
perfusion period, 20 mM-sorbitol and 5.0 mM-3-O-methylglucose,
containing 0.1 ,Ci of [U-_4C]sorbitol/ml and 2.0,Ci of 3-0-
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[3H]methylglucose/ml (final concentrations) were added to the
media. When no insulin was present in the perfusion medium, a
30 min perfusion was necessary to accumulate enough radio-
activity to accurately measure transport rates. Perfusions were
continued for only 10 min after the end of pre-perfusion when
insulin was present. The red and white portions of the gastro-
cnemius and quadriceps muscles were quickly removed, frozen in
liquid N2, homogenized in 10% trichloroacetic acid, centrifuged
and the supernatant counted for radioactivity. Accumulation of
3-O-[3H]methylglucose was corrected for the [14C]sorbitol space.
Quantification of glucose transporter protein
Approx. 100 mg of red or white quadriceps femorus muscle
was homogenized (1:6, w/v) using a Polytron homogenizer at a
setting of 7 for 15 s. Homogenization buffer contained 25 mm-
Hepes, 4 mM-EDTA, 25 mM-benzamidine and 1 ,uM of each of
leupeptin, pepstatin and aprotinin. Triton X-100 was added to a
final concentration of 1 %, then samples were incubated for 1.5 h
at 4 °C and centrifuged in a Beckman 42.2 Ti rotor at
150000 g for 35 min. Supernatants were removed and protein
content was determined (Pierce BCA). Laemmli sample buffer
(50 ,ul) containing 5% dithiothreitol was mixed with 150 ,ul
of supernatant protein and brought to a 100 1l volume with
buffer containing 25 mM-Tris, 0.19 M-glycine and 1% SDS.
SDS/PAGE (8 % gels) was used to separate proteins (Laemmli,
1970), which were then transferred to Immobilon membranes by
electrotransfer. The membrane was incubated in the primary
antibody (2 ,ug of either ECUI or ECU4/ml) followed by 1251_
labelled goat anti-(rabbit IgG). Autoradiography was carried out
for 48 h and the resulting autoradiograph was analysed by
densitometry. The polyclonal antibody ECUI was raised in
rabbits against the C-terminal peptide (prepared by Dr. Dave
Klapper, UNC, Chapel Hill, CA, U.S.A.) of Glutl by the
method of Haspel et al. (1988). ECU4 was raised against the
C-terminal peptide of Glut4 (James et al., 1989) by a similar
procedure. The antibodies were purified from rabbit serum by
passage over a Protein A-Sepharose column and used directly.
Verification of their specificity was obtained by comparison of
these autoradiographs with those generated using the I F8
(generously supplied by Dr. Paul Pilch, Boston University,
Boston, MA, U.S.A.) and anti-(erythrocyte glucose transporter)
antibodies (generously supplied by Dr. Christine Carter-Su,
University of Michigan, Ann Arbor, MI, U.S.A.).
Isolation of RNA
RNA was isolated by the method of Chirgwin et al. (1979).
Briefly, red or white muscle samples were removed from the
animal, weighed and homogenized in tissue guanidinium iso-
thiocyanate. This crude preparation was spun, and the super-
natant was removed, heated and CsCl added. This solution
was then layered over 9 ml of a 5.7 M-CsC1 solution and spun
overnight. The supernatant was removed, the pellet was resus-
pended and RNA was extracted. After quantification, RNA
species were separated on an agarose/formaldehyde gel and
blotted on to Hybond N filters (Amersham). Northern analysis
was performed using the cDNA inserts for B-actin (Cleveland
et al., 1980) as a control, and Glutl (HepG2/erythrocyte) and
Glut4 (heart/skeletal muscle/adipocyte) glucose transporters
(Kaestner et al., 1989).
RESULTS
Glucose transport
Transport rates for red portions of the gastrocnemius and
quadriceps muscles were found to be very similar, as were those
of white portions of gastrocnemius and quadriceps (Fig. 1), and
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Fig. 1. Glucose transport in red and white skeletal muscle
Dose-response curves for red and white gastrocnemius (0, 0) and
vastus (, CI) muscles (n = 10 at each insulin concentration) are
shown: 0, *, red muscle; 0, C, white muscle. Significant
differences between the fibre types were achieved at all insulin
concentrations (P < 0.05).
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Fig. 2. Glut4 and Glutl protein levels in red and white skeletal muscle
Western analysis of the Glut4 protein content using the polyclonal
antibody ECU4 (a) and of the Glutl protein content using the
polyclonal antibody ECUI (b) (50 ,ug of protein/lane) was carried
out as described in the Materials and methods section. Lane 1,
brain; lane 2, red skeletal muscle; lane 3, white skeletal muscle.
Exposure time for autoradiography was 48 h in both cases. These
results are representative of data from six separate rats in which the
results were identical.
therefore are grouped as red and white for the remainder of this
discussion. Under basal conditions (zero insulin), glucose trans-
port rates in red and white muscles were not different (Fig. 1).
When insulin was added to the perfusion medium, transport
rates of the two types of muscle diverged. At a physiological
insulin concentration (1 nM), red muscle transported twice as
much glucose as white muscle (P < 0.01). This increased to a 3.6-
fold difference at 100 nM-insulin (P < 0.001). The degree of
insulin stimulation ofglucose transport was also different between
fibre types. White muscle demonstrated a 6-fold increase from
basal transport to that at maximal insulin concentration, whereas
the red muscle was able to increase glucose transport by 17-fold.
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Fig. 3. Glutl and Glut4 mRNA content in red and white skeletal muscle
Analysis oftotal RNA (20 /sg/lane) and poly(A)+ RNA (7.5 ,ug/lane)
was carried out as described in the Materials and methods section.
The total amount of RNA isolated (,ug/g of tissue) was identical for
both red and white muscle. Hybridizations were carried out overnight
in prehybridization solution containing 0.02% each of BSA,
polyvinylpyrrolidone and Ficoll, and with the Glutl, Glut4 or B-
actin cDNA probe (1 x I07 c.p.m./ml). Hybridization and washing
were carried out under high-stringency conditions. The blot was
sequentially probed with the three cDNAs. Exposure time for
autoradiography to obtain the Glut panel was 18 h, whereas only
a 1 h exposure was required to obtain the Glut4 panel. The data are
from a representative experiment of four with different preparations
of RNA. In all cases, the results were identical.
This difference was also evident at physiological insulin concen-
trations, white muscle showing a 1.4-fold increase in transport
and red muscle demonstrating a 2.1-fold increase.
Glut4 and Glutl transporter proteins in red and white muscle
Fig. 2 shows the autoradiographs from representative Western
blots using both antibodies. Densitometric scanning revealed
5.2 times more Glut4 protein in red than in white muscle.
In contrast, no difference in GlutI protein was seen between the
fibre types (Fig. 2b). As reported previously by James et al.
(1989), brain contained an abundance of Glutl transporter and
very little Glut4 transporter (Figs. 2a and 2b).
Glut4 and Glutl mRNA levels in red and white muscle
A Northern blot representative of four separate trials is shown
in Fig. 3. Total RNA and poly(A)+ RNA gave similar results.
Scanning densitometry of the autoradiographs found total Glut
mRNA levels to be slightly higher in white than in red muscle
(22 %), but poly(A)+ was present in equal amounts in both
muscles, as was the control mRNA, actin (Fig. 3). By contrast,
levels of Glut4 poly(A)+ mRNA and total RNA were 2-fold
greater in red compared with white (Figs. 3 and 4). Attention
should be drawn to the different exposure times needed to
visualize these different messages (see the Fig. legends).
DISCUSSION
The findings of the present study suggest that glucose transport
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Fig. 4. Comparisons between maximal transport rate, Glut4 protein level
and Glut4 mRNA in red (U) and white (El) muscle
(a) Similarities between maximal transport rate (100 nM-insulin), as
measured in the perfused hindquarter (n = 10 per group; left-hand
bars), and Glut4 protein level (n = 6 per group; right-hand bars), as
determined by Western analysis (P < 0.001 for the difference between
red and white muscle for both parameters). (b) Glut4 protein level
(left-hand bars) is compared with Glut4 mRNA levels (right-hand
bars), as determined by Northern analysis.
in specific skeletal muscle fibre types is at least partially, if not
entirely, dependent upon the total amount of Glut4 glucose
transporter protein, since glucose transport and Glut4 were both
greater in red than in white muscle. Data from the Western
analysis agree with previously reported cytochalasin B binding
data (Kern et al., 1989), in that more total transporters were
found in red than white muscle. More specifically, this difference
is due to the Glut4 transporter isoform (5 times more). Moreover,
the steady-state red muscle Glut4 mRNA level is 2 times higher
than that in white muscle, suggesting that red skeletal muscle
preferentially expresses more Glut4 mRNA as well as protein
(Fig. 4). Because this protein plays such an integral part in
glucose transport in skeletal muscle, it suggests that the greater
expression of Glut4 in red skeletal muscle may explain the
cellular mechanism for the observed difference in insulin re-
sponsiveness in red and white muscle, and this same mechanism
may be responsible for various insulin-resistant states.
These results beg the question of which factors regulate the
expression of the Glut4 transporter in the two fibre types. Their
innervation is very different (Edington & Edgerton, 1976), as is
their oxidative capacity (Romanul, 1965; Nemeth & Pette, 1981)
and capillarization (Lillioja et al., 1987). After chronic nerve
stimulation or endurance training, white fibres take on
characteristics more like those of red muscle. Perhaps the neural
input during endurance activity (already present in the red
muscle) serves to regulate expression of a number of genes
(Williams et al., 1987), which could include the Glut4 gene.
The relationship between capillary density, fibre types and
glucose transport could possibly be explained by the recent
results of Vilaro' et al. (1989). Using immunofluorescence, they
found the Glut4 transporter to be largely present in the endo-
thelial cells of non-fenestrated capillaries, and conspicuously
absent within the skeletal muscle itself. Red muscle is more
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vascularized than white muscle and thus this finding would be
consistent with the observations reported here. However, pre-
liminary experiments in our laboratory using immunocyto-
chemistry (Dudek et al., 1990) have been unable to confirm the
findings of Vilaro' et al. (1989), and by contrast found Glut4 to
be present exclusively within the muscle cell.
An alternative way to look at this situation is to think of white
muscle as having a depressed rate of Glut4 synthesis, resulting in
an 'insulin-resistant' state. A recent article by Mueckler (1990)
proposes a scenario in which a reduction in skeletal muscle
glucose transporters could result in insulin resistance and non-
insulin-dependent diabetes. He suggests that factors regulating
glucose transporters in skeletal muscle could explain insulin
resistance. As mentioned earlier, streptozotocin-diabetic rats
demonstrate a decrease in the total number of glucose
transporters, and this has been suggested to be responsible for
the diminished glucose uptake seen in diabetic muscle (Ramlal
et al., 1989). These results are very similar to the results shown
here between red and white muscle.
In summary, the differences between red and white muscle
described in this paper indicate that the level of the Glut4
transporter protein appears to be a major determinant in the
muscles' ability to respond to insulin. Discovery of mechanisms
by which skeletal muscle regulates this key protein may provide
important clues and information regarding the mechanism(s) of
insulin resistance.
This work was supported by National Institutes of Health Grant
ROI-DK-38416. M.K. was supported by a Postdoctoral Fellowship
(F32-DK08273) from the National Institutes of Health.
REFERENCES
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J. & Rutter, W. J.
(1979) Biochemistry 18, 5294-5299
Cleveland, D. W., Lopata, M. A., MacDonals, R. J., Cowan, N. J.,
Rutter, W. J. & Kirschner, M. W. (1980) Cell 20, 95-105
Defronzo, R. A., Gunnarsson, R., Bjorkman, O., Olsson, M. & Wahren,
J. (1985) J. Clin. Invest. 76, 149-155
Dohm, G. L., Kasperek, G. J., Tapscott, E. B. & Beecher, G. R. (1980)
Biochem. J. 188, 255-262
Dohm, G. L., Tapscott, E. B., Pories, W. J., Dabbs, D. J., Flickinger, E.
G., Meelheim, D., Fushiki, T., Atkinson, S. M., Elton, C. W. & Caro,
J. F. (1988) J. Clin. Invest. 82, 486-494
Dudek, R. W., Friedman, J. E., Whitehead, D., Leggett-Frazier, N. &
Dohm, G. L. (1990) Diabetes 39 (suppl. 1), 82A
Edington, D. W. & Edgerton, V. R. (1976) The Biology of Physical
Activity, pp. 51-72, Houghton Mifflin Co., Boston
Haspel, H. C., Rosenfeld, M. G. & Rosen, 0. M. (1988) J. Biol. Chem.
263, 398-403
James, D. E., Jenkins, A. B. & Kraegen, E. W. (1985) Am. J. Physiol.
248, E567-E574
James, D. E., Strube, M. & Mueckler, M. (1989) Nature (London) 338,
83-87
Kaestner, K. H., Christy, R. J., McLenithan, J. C., Braiterman, L. T.,
Cornelius, P., Pekala, P. H. & Lane, M. D. (1989) Proc. Natl. Acad.
Sci. U.S.A. 86, 3150-3154
Kahn, B. B., Charron, M. J., Lodish, H. F., Cushman, S. W. & Flier,
J. S. (1989) J. Clin. Invest. 84, 404-411
Kern, M., Tapscott, E. B. & Wells, J. A. (1989) Diabetes 38, 65A
Krotkiewski, M. & Bjorntrop, P. (1986) Int. J. Obesity 10, 331-341
Laemmli, U. K. (1970) Nature (London) 227, 680-685
Lillioja, S., Young, A. A., Culter, C. L., Ivy, J. L., Abbott, W. G. H.,
Zawadzki, J. K., Yki-Jarvinen, H., Christin, L., Secomb, T. W. &
Bogardus, C. (1987) J. Clin. Invest. 80, 415-424
Mueckler, M. (1990) Diabetes 39, 6-11
Nemeth, P. & Pette, D. (1981) J. Physiol. (London) 320, 73-80
Ramlal, T., Rastogi, S., Vranic, M. & Klip, A. (1989) Endocrinology
(Baltimore) 125, 890-897
Richter, E. A., Hansen, B. F. & Hansen, S. A. (1988) Biochem. J. 252,
733-737
Romanul, F. C. A. (1965) Arch. Neurol. 12, 497-509
Vilaro', S., Palacin, M., Pilch, P. F., Testar, X. & Zorzano, A. (1989)
Nature (London) 343, 798-800
Wallberg-Henriksson, H. (1987) Acta Physiol. Scand. 131 (suppl.), 564
Williams, R. S., Garcia-Moll, M., Mellor, J., Salmons, S. & Harlan, W.
(1987) J. Biol. Chem. 262, 2764-2767
Received 12 February 1990/25 April 1990; accepted 10 May 1990
1990
400
